Sysmex (OTCMKTS:SSMXY) Sets New 1-Year Low at $15.68

Sysmex Co. (OTCMKTS:SSMXY - Get Free Report)'s stock price hit a new 52-week low on Monday . The company traded as low as $15.68 and last traded at $15.70, with a volume of 96602 shares traded. The stock had previously closed at $16.01.

Sysmex Trading Down 1.9 %

The business's 50 day moving average price is $17.66 and its two-hundred day moving average price is $17.52. The company has a market capitalization of $9.88 billion, a price-to-earnings ratio of 30.99 and a beta of 0.66. The company has a debt-to-equity ratio of 0.10, a quick ratio of 2.27 and a current ratio of 3.10.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last released its earnings results on Friday, February 9th. The company reported $0.13 earnings per share for the quarter, missing analysts' consensus estimates of $0.16 by ($0.03). The firm had revenue of $770.84 million during the quarter. Sysmex had a return on equity of 11.15% and a net margin of 10.25%. Equities analysts forecast that Sysmex Co. will post 0.53 earnings per share for the current fiscal year.

About Sysmex

(Get Free Report)

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

Further Reading

Should you invest $1,000 in Sysmex right now?

Before you consider Sysmex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sysmex wasn't on the list.

While Sysmex currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Featured Articles and Offers

Search Headlines: